Thymosin and Immune-Signaling Research

Immune-signaling research peptides are studied for their interaction with innate and adaptive immune pathways at the cellular level — antigen presentation, T-cell maturation, cytokine expression, and direct antimicrobial activity against membrane structures. The category includes Thymosin Alpha-1, a 28-amino-acid thymic peptide examined in T-cell activation and cytokine-signaling research; and LL-37, the mature antimicrobial fragment of human cathelicidin antimicrobial protein hCAP18, characterized in innate-immune and membrane-interaction literature. Both are long, structurally sensitive sequences. LL-37 in particular is a 37-residue amphipathic helix whose synthesis and purification are analytically demanding, which makes independent lot verification more consequential here than in shorter-sequence categories. Full HPLC and mass-spec data for every lot are published in the COA Library. All products in this category are supplied strictly for laboratory research use. They are not drugs, not dietary supplements, and are not for human or veterinary use.